Quantcast

New Procedures to Drive Growth of $5 Billion Global Medical Aesthetic Industry

February 23, 2009

Global Aesthetic Market Study from Medical Insight, Inc. Provides Comprehensive Insights, Data and Forecasts

ALISO VIEJO, Calif., Feb. 23 /PRNewswire/ — Over the next five years, new skin tightening and body shaping devices, dermal fillers and neuromodulators will drive double-digit growth in the global aesthetic industry, according to the newest Global Aesthetic Market VI research report from Medical Insight, Inc.

The 500-page GAM VI study, which is the only published report providing comprehensive and in-depth global analysis of the entire $5 billion aesthetic industry, describes in detail how, despite a softening economy, advanced new aesthetic products will play prominent roles in boosting industry sales to $8.2 billion by 2012. Among highlights in the sixth edition of this semi-annual forecast:

  • Skin Tightening will expand by 21.3% per year from $79.3 million in 2008 equipment revenues to $171.4 million in 2012;
  • Body Shaping devices will rise from $361.9 million in global supplier sales to $752.9 million by 2012, for 20.1% annual growth;
  • Dermal Filler sales will expand by 15.6% per year from $822.6 million in 2008 to $1.4 billion in 2012;
  • Neuromodulators will grow by 14.8% annually from $898.6 million in 2008 to $1.5 billion in 2012 with the introduction of new products to compete with Botox.

“Although the aesthetic device industry contracted in 2008 due to a deepening global recession, consumer demand for cost effective treatments that address significant age-related problems represent a highly sustainable long-term market,” said Michael Moretti, president of Medical Insight, Inc. and editor of the GAM VI study. “Skin tightening and body shaping are new technologies that meet this need, while popular facial injectables like Restylane and Botox continue to be utilized as a quick, affordable way to erase wrinkles. These products will offset lower growth in the mature energy device market segment, driving overall expansion of 13.1% per year from 2008 to 2012.”

Procedure volume for all aesthetic treatments will rise by 5.6% per year from 81 million in 2008 to 101 million in 2012. During this time, total fees earned by practitioners will expand by 6.1% annually from $31 billion to $39 billion.

Public companies detailed in GAM VI include Allergan, Bioform, Candela, Cutera, Cynosure, Medicis, Mentor, Obagi, Palomar, Solta, Syneron and more than three dozen others, including the leading startup players.

For more information and to preview a table of contents and Executive Summary, visit www.miinews.com.

To download a detailed Market Forecast, go to: http://www.miinews.com/pdf/jan_feb_09/MarketForecast_TAG0109v3-020609.pdf

About Medical Insight, Inc.

Medical Insight, Inc. is the industry leader in syndicated and custom research for the aesthetic market. Under the leadership of Michael Moretti, Medical Insight Inc. has collected data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trends, delivering detailed analyses that are used by the industry’s top decision makers.

    Contact: Michael Moretti
             Medical Insight, Inc.
             (949) 830-5409
             Email: Mmoretti@MiiNews.com

SOURCE Medical Insight, Inc


Source: newswire



comments powered by Disqus